Wuhan Keqian Biology Co.,Ltd (SHA:688526)

SHA:688526 Revenue

Wuhan Keqian Biology Co.,Ltd had revenue of 201.07M CNY in the quarter ending September 30, 2026, a decrease of -19.76%. This brings the company's total for the last twelve months to 786.77M, down -22.43% year-over-year. In the year 2025, Wuhan Keqian Biology Co.,Ltd had annual revenue of 949.74M with 0.83% growth. That makes Wuhan Keqian Biology Co.,Ltd the 21,432nd largest company in the world by revenue and 3,939th in China.

• Revenue (ttm): 786.77M
• Revenue Growth: -22.43%
• P/S Ratio: 6.90
• Revenue / Employee: 841.47K
• Employees: 935
• Market Cap: 5.44B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Veterinary Biological Products Industry 890.43M 95.2%
• Other 45.22M 4.8%

Fiscal year ended Dec 31, 2025 See the full SHA:688526 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	949.74M	7.82M	0.83%
Dec 31, 2024	941.92M	-122.15M	-11.48%
Dec 31, 2023	1.06B	62.81M	6.27%
Dec 31, 2022	1.00B	-101.75M	-9.22%
Dec 31, 2021	1.10B	259.79M	30.81%

Data Source: S&P Global Market Intelligence Last updated: Oct 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 5, 2026

Data Sources Report a data error